Biosimilar Patent Disputes What the Early Wave of Litigation Signals for the Future


Since the formalisation of the new BPCIA framework in 2014, we have seen a wave of patent infringement suits filed leading to a trend of innovator-versus-biosimilar disputes. What are the trends shown by these early suits, and what legal and strategic questions do they raise? The panel will discuss: